Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on August 28, 2007
JNCI Journal of the National Cancer Institute 2007 99(17):1279-1280; doi:10.1093/jnci/djm129
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/17/1279    most recent
djm129v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Crawford, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crawford, E. D.
Related Collections
Right arrowCorrespondence about this Article
Right arrowRelated Articles in JNCI
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

EDITORIALS

Is a Screening Interval of Every 4 Years for Prostate Cancer Acceptable?

E. David Crawford

Correspondence to: E. David Crawford, MD, Division of Urologic Oncology, University of Colorado Health Sciences Center, Mail Stop # F 710, PO Box # 6510, Aurora, CO 80045 (e-mail: david.crawford@uchsc.edu).

The first 10% of the full text of this article appears below.

In this issue of the Journal, Roobol et al. (1) report an analysis of two different screening intervals in the large European Randomized study of Screening for Prostate Cancer (ERSPC) to defend a screening interval of every 4 years. In contrast to the yearly screening for prostate cancer in the United States, most centers in the ERSPC trial chose to screen men every 4 years. Critics of the 4-year screening interval have voiced concerns that clinically significant cancers could be missed by such an extended interval. The . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Correspondence about this Article

Re: Is a Screening Interval of Every 4 Years for Prostate Cancer Acceptable?
Monique J. Roobol and Fritz H. Schröder
J Natl Cancer Inst 2008 100: 222. [Extract] [Full Text] [PDF]

Related Articles in JNCI

Interval Cancers in Prostate Cancer Screening: Comparing 2- and 4-Year Screening Intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam
Monique J. Roobol, Anna Grenabo, Fritz H. Schröder, and Jonas Hugosson
J Natl Cancer Inst 2007 99: 1296-1303. [Abstract] [Full Text] [PDF]

Press Release: Drop in Breast Cancer Incidence Linked to Hormone Use, Not Mammograms
Liz Savage and Andrea Widener
J Natl Cancer Inst 2007 99: 1277. [Extract] [Full Text] [PDF]

IN THIS ISSUE
J Natl Cancer Inst 2007 99: 1277. [Extract] [Full Text] [PDF]

Press Release: More Prostate Cancer Screening Has Little Effect on Detection of Aggressive Cancer
Liz Savage and Andrea Widener
J Natl Cancer Inst 2007 99: 1277. [Extract] [Full Text] [PDF]

Press Release: Hypnosis Reduces Pain and Costs in Breast Cancer Surgery
Liz Savage and Andrea Widener
J Natl Cancer Inst 2007 99: 1277. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
JWatch Oncology and HematologyHome page
Is Less-Intensive Prostate Cancer Screening Appropriate?
Journal Watch Oncology and Hematology, October 2, 2007; 2007(1002): 2 - 2.
[Full Text]